JPMorgan says that the injectables business of Aurobindo Pharma incorporates $1.4bn U.S. franchise
In its report, JPMorgan says that the injectables business of Aurobindo Pharma incorporates the $1.4bn U.S. franchise (likely the best
Read moreIn its report, JPMorgan says that the injectables business of Aurobindo Pharma incorporates the $1.4bn U.S. franchise (likely the best
Read more